These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15021215)

  • 21. Physiological approaches to neuroprotection. boosting of protective autoimmunity.
    Schwartz M
    Surv Ophthalmol; 2001 May; 45 Suppl 3():S256-60; discussion S273-6. PubMed ID: 11377445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma.
    Ebneter A; Chidlow G; Wood JP; Casson RJ
    Arch Ophthalmol; 2011 Oct; 129(10):1337-44. PubMed ID: 21987677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma.
    Schori H; Kipnis J; Yoles E; WoldeMussie E; Ruiz G; Wheeler LA; Schwartz M
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3398-403. PubMed ID: 11248090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head.
    Tezel G; Luo C; Yang X
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1201-11. PubMed ID: 17325164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss.
    Nuschke AC; Farrell SR; Levesque JM; Chauhan BC
    Exp Eye Res; 2015 Dec; 141():111-24. PubMed ID: 26070986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinal and Optic Nerve Damage is Associated with Early Glial Responses in an Experimental Autoimmune Glaucoma Model.
    Noristani R; Kuehn S; Stute G; Reinehr S; Stellbogen M; Dick HB; Joachim SC
    J Mol Neurosci; 2016 Apr; 58(4):470-82. PubMed ID: 26746422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoreactive antibodies and loss of retinal ganglion cells in rats induced by immunization with ocular antigens.
    Laspas P; Gramlich OW; Müller HD; Cuny CS; Gottschling PF; Pfeiffer N; Dick HB; Joachim SC; Grus FH
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8835-48. PubMed ID: 22003114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pathogenesis of glaucoma in the interplay with the immune system.
    Rieck J
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2393-409. PubMed ID: 23539162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.
    Bosco A; Inman DM; Steele MR; Wu G; Soto I; Marsh-Armstrong N; Hubbard WC; Calkins DJ; Horner PJ; Vetter ML
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1437-46. PubMed ID: 18385061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effect of lignans extracted from Eucommia ulmoides Oliv. on glaucoma-related neurodegeneration.
    Li CP; Qiu GZ; Liu B; Chen JL; Fu HT
    Neurol Sci; 2016 May; 37(5):755-62. PubMed ID: 26829935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy.
    Levin LA
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S98-101. PubMed ID: 10416753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma.
    Gramlich OW; Teister J; Neumann M; Tao X; Beck S; von Pein HD; Pfeiffer N; Grus FH
    J Neuroinflammation; 2016 Apr; 13(1):82. PubMed ID: 27090083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Distal axonopathy in glaucomatous optic neuropathy].
    Zhang X; Liu S; Yi J
    Zhonghua Yan Ke Za Zhi; 2014 May; 50(5):391-4. PubMed ID: 25052808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation.
    Schwartz M; London A
    Prog Brain Res; 2008; 173():375-84. PubMed ID: 18929122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma.
    Neufeld AH
    Arch Ophthalmol; 1999 Aug; 117(8):1050-6. PubMed ID: 10448748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The challenge of regenerative therapies for the optic nerve in glaucoma.
    Calkins DJ; Pekny M; Cooper ML; Benowitz L;
    Exp Eye Res; 2017 Apr; 157():28-33. PubMed ID: 28153739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should we treat the brain in glaucoma?
    Gupta N; Yücel YH
    Can J Ophthalmol; 2007 Jun; 42(3):409-13. PubMed ID: 17508036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules.
    Yang L; Li S; Miao L; Huang H; Liang F; Teng X; Xu L; Wang Q; Xiao W; Ridder WH; Ferguson TA; Chen DF; Kaufman RJ; Hu Y
    J Neurosci; 2016 May; 36(21):5891-903. PubMed ID: 27225776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glial coverage in the optic nerve expands in proportion to optic axon loss in chronic mouse glaucoma.
    Bosco A; Breen KT; Anderson SR; Steele MR; Calkins DJ; Vetter ML
    Exp Eye Res; 2016 Sep; 150():34-43. PubMed ID: 26851485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.